Cervix
- 14 August 2015
- book chapter
- Published by Wiley
- p. 449-466
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Detection of cervical cancer recurrence during follow-up: A multivariable comparison of 9 frequently investigated serum biomarkersGynecologic Oncology, 2013
- Worldwide burden of cervical cancer in 2008Annals of Oncology, 2011
- Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy for the Definitive Treatment of Cervix CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyThe Lancet Oncology, 2010
- Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2009
- Human Papillomavirus Infection and Cervical Disease in Human Immunodeficiency Virus-1–Infected WomenObstetrics & Gynecology, 2008
- Multimodality Therapy for Locally Advanced Cervical Carcinoma: State of the Art and Future DirectionsJournal of Clinical Oncology, 2007
- Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trialThe Lancet, 2006
- Is lymph vascular space involvement an independent prognostic factor in early cervical cancer?Gynecologic Oncology, 2004
- HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort studyThe Lancet, 2002